Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 10,000 shares at $57.16 ($573K) on 2026-07-06, disclosed to the SEC on 2026-07-06.
Scheduled sale ($573k) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.16 | 7,913 | $452K | 79.0% |
| 2 | $57.76 | 2,087 | $121K | 21.0% |
| Total | $57.28 avg | 10,000 | $573K | 100% |
| Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |
| PCVX | SELL | 2024-12-19 | $1.4M | — | Filing → |